This CE activity serves to promote the process of life-long learning for physicians, dietitians, pharmacists, and nurses who specialize in the sciences of clinical nutrition and metabolism.
Goal and Target Audience:
This educational activity is directed toward clinical nutrition and metabolism professionals and others who wish to update their knowledge of clinical nutrition and metabolism. By participating in this educational activity, the reader may expect to:
Acquire knowledge in the area of clinical nutrition and metabolism research
Update or confirm your understanding of appropriate clinical nutrition and metabolism practices.
Identify further learning needs as they relate to the subject matter.
Discuss the role of specific pharmaconutrients (ie. Selenium) and nutritional interventions such as protein delivery in outcome from critical care and surgery
Discuss future role of probiotics and the microbiome in diagnosis and therapy in the ICU and other clinical settings
Discuss what has been learned from the REDOX trial on glutamine and antioxidants regarding future clinical use of these nutrients in practice
Requirements for Successful Completion:
To obtain CE credit for this activity, attendees must listen to the education recording, complete an online knowledge assessment for each education recording and achieve a score of 100%, and complete an online activity evaluation. All CE credit must be claimed prior to the expiration date.
The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
A.S.P.E.N. designates each enduring activity for a maximum of 1.5 contact hours (0.15 CEU) per activity. All are knowledge activities.
A.S.P.E.N. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™ per activity. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A.S.P.E.N. is approved by the California Board of Registered Nursing, Provider CEP 3970.
ACPE UAN: 216-0000-15-69-H01-P
A.S.P.E.N., Provider Number AM005, is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR level 2. Dietitians may post comments on this program on www.cdrnet.org.
Non-Commercialism: A.S.P.E.N. subscribes to the ACCME Standards for Commercial Support. A.S.P.E.N. does not provide programs that constitute advertisement or include promotional materials. A.S.P.E.N. does not endorse any products.
Privacy and Confidentiality: A.S.P.E.N. respects the privacy of its members and website visitors. Companies that receive personal information from A.S.P.E.N. in order to execute the business of A.S.P.E.N. may use personal information only for that purpose.
Refund Policy: Refunds are not available.
Grievances: Grievances must be submitted in writing to Director of Education atA.S.P.E.N. 8630 Fenton Street. Suite 412. Silver Spring, MD 20910.
Commercial Support and Sponsorship:
No commercial support or sponsorship has been received for this continuing education activity.
Commercial Relationships Disclosures and Conflicts of Interest (COI) of Speakers/Facult:
Robert Martindale: Abbott, Merck and LifeCell, Consulting Fees and Speaker Honorarium; No apparent conflict, content or role not related to established relationship with commercial entity.
Thomas Schricker: Baxter Advisory Board, honorarium, speaking; Conflict resolved through included practice recommendations being based on formal structured review of literature and must state inclusion and exclusion criteria.
Gunnar Elke: Fresenius Kabi, honoraria, speaker/ B.Braun Melsungen, Travel expenses, Advisory Board member; No apparent conflict, content or role not related to established relationship with commercial entity.
Daren Heyland: Nestle, Fresenius Kabi, Abbott and Baxter, Research Funding, Other Activities/ Nestle, Fresenius Kabi, Abbott and Baxter, Honoraria;Conflict resolved through peer review methodology.
Department of Anaesthesiology and Intensive Care Medicine,
University Medical Center Schleswig-Holstein
Director, Clinical Evaluation Research Unit, Kingston General Hospital; Director, The Canadian Researchers at the End of Life Network; Director, Critical Care Nutrition,
Queen's University, Kingston, Ontario, Canada
Professor & Chief, Division of General Surgery,
Oregon Health & Science University, Portland, OR
Associate Professor and Clinical Director, Department of Anesthesia,
Royal Victoria Hospital, McGill University
Credits: None available.
You must be logged in and own this session in order to